A malaria drug touted by US President Donald Trump as a “game changer” in the fight against Covid-19 has been in high demand in New Zealand, leading Pharmac to put restrictions on its use. But the government drug-buying agency says hydroxychloroquine will still be available for DHBs which are now in
by Mike Sanford